Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

Document Details

Filing Date
Nov 8, 2024
Document Date
Nov 8, 2024
Form Description
A statement of beneficial ownership of common stock by certain persons
Filing Group
Other
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/